NEUROLOGIX SIGNS STRATEGIC LICENSE AGREEMENT FOR COMPONENT OF ITS PARKINSON'S GENE THERAPY PRODUCT

Neurologix, Inc., a biotech company committed to developing innovative gene therapies for the brain and central nervous system, announced that it has entered into a licensing agreement with a subsidiary of Diamyd Medical, a biotechnology company based in Stockholm, Sweden, and Pittsburgh, PA.
Business Wire